Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03285425 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Natural History of Neuronal Ceroid Lipofuscinosis, Batten's CLN6 Diseae

Study acronym: Batten'sCLN6
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Jan 2025 to Dec 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v7
  2. Primary and study completion dates: Jan 2022 to Jan 2025v6
  3. Re-verified, no change to tracked fieldsv5
  4. Site contact updatedv4
  5. Enrollment target: 15 to 30
    • Primary and study completion dates: Jan 2020 to Jan 2022
    v3
  6. Re-verified, no change to tracked fieldsv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
CLN6 is a rare, neurodegenerative disease that causes progressive loss of acquired skills with motor delay, visual loss, seizures and ataxia. The investigators propose a natural history study of this rare disorder since it is currently unknown. It is important to understand disease progression in CLN6 disease to be able to judge therapeutic efficacy as emerging therapies like gene therapy become available.
Trial Details
NCT Number NCT03285425
Lead Sponsor Emily de los Reyes
Conditions
(from sponsor)		 Batten Disease, CLN6
Related terms Neuronal Ceroid-Lipofuscinoses
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov